Similar drugsTo uncover Dosage form: & nbsporal solution Composition:Active Ingredient: root extract extract dry (4-6: 1) (in terms of Uzarin) 40 mg, extractant 60% methyl alcohol; auxiliary ingredients: ethanol 96% (v / v), disodium edetate dihydrate, purified water - up to 1 ml. Description:Transparent solution from light brown to brown color, slight opalescence is allowed. Pharmacotherapeutic group:Antidiarrhoeic remedy ATX: & nbspDrugs that reduce the peristalsis of the digestive tract Pharmacodynamics:The antidiarrhoeal effect of Uzara® is associated with stimulation of the sympathetic nervous system with glycosides (active ingredients of Uzara®), which results in a weakening of the intestinal motility and normalization of the stool.In addition to suppressing the motility of the digestive tract, the active substances of Uzara® have antispasmodic, antisecretory, astringent and enveloping effects. Indications:Nonspecific acute diarrhea. Contraindications:Hypersensitivity to the components of the drug, simultaneous reception of cardiac glycosides, alcoholism, children's age (up to 12 years). Carefully:Patients with liver disease, epilepsy and brain damage should take Uzara ®, a solution for oral administration, only after consulting a doctor because of the content of ethyl alcohol. Pregnancy and lactation:In experimental studies of teratogenic, mutagenic properties of the drug Uzara® was not revealed. Until now, there have been no reports of any developmental defects in the use of the drug. Since the clinical experience of using the drug in pregnant and lactating women is very limited, the Uzara® drug should be used only under strict indications, when the prospective benefit to the mother exceeds the potential risk to the fetus and the baby. Dosing and Administration:Inside, regardless of food intake.Adults and children over 12 years of age: the initial dose on the first day - 5 ml of solution once, on subsequent days - 1 ml of solution 3-6 times a day before the normalization of the stool. Side effects:Allergic reactions. Interaction:With simultaneous use with drugs quinidine, calcium, diuretics (saluretics) or long-term therapy with cortisone drugs, there may be violations of the heart rhythm. Special instructions:If the duration of diarrhea exceeds 2 days, it is accompanied by high body temperature, and if there are impurities in the stool, you should immediately consult a doctor. Form release / dosage:Solution for oral administration 40 mg / ml. Packaging:For 30 or 100 ml of the drug in a bottle of dark glass, sealed with a stopper-dropper made of polyethylene and a screw cap made of polypropylene. A bottle with a measuring cap and instructions for medical use of the drug are placed in a cardboard box. Storage conditions:At a temperature of no higher than 25 ° C.In a place inaccessible to children. Shelf life:3 years. Do not use the drug after the expiration date.After opening the vial, use the solution for 12 months. Terms of leave from pharmacies:On prescription Registration number:LSR-003620/10 Date of registration:30.04.2010 The owner of the registration certificate:SHTADA Artznajmittel AGSHTADA Artznajmittel AG Germany Manufacturer: & nbspSTADA Arzneimittel, AG Germany Representation: & nbspNizhpharm, JSCNizhpharm, JSCRussia Information update date: & nbsp2016-02-03 Illustrated instructions × Illustrated instructions Instructions